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Background. Major depressive disorder (MDD) is a common and disabling condition with well-established heritability
and environmental risk factors. Gene–environment interaction studies in MDD have typically investigated candidate
genes, though the disorder is known to be highly polygenic. This study aims to test for interaction between polygenic
risk and stressful life events (SLEs) or childhood trauma (CT) in the aetiology of MDD.
Method. The RADIANT UK sample consists of 1605 MDD cases and 1064 controls with SLE data, and a subset of 240
cases and 272 controls with CT data. Polygenic risk scores (PRS) were constructed using results from a mega-analysis on
MDD by the Psychiatric Genomics Consortium. PRS and environmental factors were tested for association with case/con-
trol status and for interaction between them.
Results. PRS signiﬁcantly predicted depression, explaining 1.1% of variance in phenotype (p = 1.9 × 10−6). SLEs and CT
were also associated with MDD status (p = 2.19 × 10−4 and p = 5.12 × 10−20, respectively). No interactions were found be-
tween PRS and SLEs. Signiﬁcant PRSxCT interactions were found (p = 0.002), but showed an inverse association with
MDD status, as cases who experienced more severe CT tended to have a lower PRS than other cases or controls. This
relationship between PRS and CT was not observed in independent replication samples.
Conclusions. CT is a strong risk factor for MDD but may have greater effect in individuals with lower genetic liability
for the disorder. Including environmental risk along with genetics is important in studying the aetiology of MDD and
PRS provide a useful approach to investigating gene–environment interactions in complex traits.
Received 14 May 2015; Revised 22 September 2015; Accepted 22 September 2015; First published online 3 November 2015
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Introduction
Major depressive disorder (MDD) is a global public
health problem and the second leading cause of
disability worldwide (Vos et al. 2012). The disorder
has a well-established genetic contribution, with a her-
itability of 37% (Sullivan et al. 2000). Genome-wide as-
sociation studies (GWAS) on depression have typically
failed to identify the speciﬁc genetic variants involved
(Ripke et al. 2013), although two loci have recently been
implicated in the CONVERGE study of Chinese
women with severe MDD (CONVERGE Consortium,
2015). Many environmental risk factors also increase
the risk of depression, including unemployment, social
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isolation and relationship stressors (Brown & Harris,
1978). Stressful life events (SLEs) can trigger new depres-
sive episodes and childhood trauma (CT) has been
shown to double the risk for depression in adulthood
(Kessler, 1997; Kendler et al. 1999; Nanni et al. 2012).
Gene–environment interactions (GxEs) whereby a
person inherits sensitivity to environmental factors
could also play an important role in MDD (Uher,
2014). GxEs have commonly been investigated using
single loci in candidate genes, for example the sero-
tonin transporter promoter polymorphism (5-HTTLPR)
and its interaction with SLEs in major depression
(Caspi et al. 2003). Despite this being the most widely
investigated GxE in psychiatry, numerous studies in-
cluding meta-analyses have produced discrepant
results (Risch et al. 2009; Karg et al. 2011; Uher, 2014).
There is more consistent evidence for an interaction be-
tween 5-HTTLPR and CT, conferring risk for persistent
depression in adulthood (Karg et al. 2011; Uher et al.
2011; Brown et al. 2013; Fisher et al. 2013).
Nevertheless, the conﬂicting results from GxE studies
in psychiatry have made these ﬁndings controversial
(Duncan & Keller, 2011).
Further analyses of the genetic effects on MDD have
indicated that the disorder is likely to be highly poly-
genic, arising from the combined effect of many risk
variants, each with small effect sizes (Wray et al.
2012; Ripke et al. 2013). Polygenic risk scoring can be
used to test the predictive power of multiple genetic
variants simultaneously. Subsets of single nucleotide
polymorphisms (SNPs) from a discovery GWAS are
selected according to their p value and weighted by
their effect size to create a polygenic risk score (PRS)
for each individual in an independent validation sam-
ple. The PRS can then be tested for its ability to differen-
tiate between case and control status in the validation
dataset (Purcell et al. 2009; Dudbridge, 2013). PRS
derived using results from the largest GWAS on MDD
by the Psychiatric Genomics Consortium have shown
signiﬁcant predictive ability for depression, explaining
about 0.9% of variance in case–control samples (Ripke
et al. 2013; Peyrot et al. 2014).
These ﬁndings have led to the hypothesis that GxEs
in a highly polygenic trait such as MDD may involve
multiple genetic variants rather than one speciﬁc
locus. Indeed, interactions between polygenic scores
for MDD and CT were found to increase risk for de-
pression in the Netherlands Study of Depression and
Anxiety (NESDA), accounting for 0.6% of variance in
MDD status (Peyrot et al. 2014). The dearth of signiﬁ-
cant results in GWAS of MDD may be partially due
to environmental inﬂuences not being accounted for
and investigation of GxEs could provide important
insights into the complex aetiology of the disorder.
Here we test for interactions between polygenic risk
for major depression and adult SLEs or CT in the
RADIANT UK study of recurrent MDD.
Method
Clinical sample collection
Depression cases (n = 1605) were drawn from three
studies previously described in the published litera-
ture. The RADIANT UK recurrent MDD sample is
comprised of the Depression Case Control (DeCC)
study and probands from the Depression Network
(DeNT) study of affected sibling pairs (Farmer et al.
2004; Cohen-Woods et al. 2009). UK-ascertained cases
from the Genome Based Therapeutic Drugs for
Depression (GENDEP) study were also included.
GENDEP is a prospective pharmacogenetic study of
patients with unipolar depression of at least moderate
severity, on a 12-week antidepressant treatment (Uher
et al. 2010). Brieﬂy, patients were diagnosed using the
Schedules for Clinical Assessment in Neuropsychiatry
Interview, according to standardized criteria (Wing
et al. 1990). Information was recorded on patients’
worst and second worst episodes of depression in the
DeCC and DeNT studies and on their current episode
in the GENDEP study (Lewis et al. 2010). Exclusion cri-
teria included personal or family history of other psy-
chiatric diagnoses besides anxiety disorder (Farmer
et al. 2004; Cohen-Woods et al. 2009; Uher et al. 2010).
Healthy controls (n = 1064) were available from the
DeCC study and the London site of the Bipolar
Affective Disorder Case–Control study (Gaysina et al.
2009; Lewis et al. 2010). Controls were screened for life-
time absence of all psychiatric disorders using the Past
History Schedule (McGufﬁn et al. 1986). First-degree
family history of any psychiatric disorder or a score
of 10 or more on the Beck Depression Inventory at
interview were further exclusion criteria (Beck et al.
1996; Cohen-Woods et al. 2009, 2010).
Replication analysis was conducted using recurrent
depression cases from The Genetics of Recurrent
Early-Onset Depression (GenRED) 1 study (n = 260),
the GenRED 2 study (n = 270) and the Depression
Genes and Networks (DGN) study (n = 469) (Shi et al.
2011; Battle et al. 2014). Individuals in all analyses
were of white European parentage and gave written
informed consent to participate. Further information
on clinical samples is provided in the online
Supplementary material.
Measures
Recurrent MDD was deﬁned according to standard cri-
teria, as having at least two episodes of moderate se-
verity, separated by two or more months of
remission (World Health Organization, 1993;
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American Psychiatric Association, 1994). Number of
episodes was not a requirement in the GENDEP
study, although the majority of cases were recurrent
(Lewis et al. 2010).
Whole-blood samples were collected in
ethylene-diamine-tetra-acetic acid (EDTA) from
depressed cases. DNA samples were collected from
controls by taking blood or using buccal mucosa
swabs returned via postal mail. DNA was extracted
and samples of sufﬁcient quantity and quality were
genotyped on the Illumina Human610-Quad
BeadChip (Illumina, Inc., USA) (Freeman et al. 2003;
Lewis et al. 2010).
Adult SLEs were assessed using the Brief Life Event
Questionnaire, which is a shortened version of the List
of Threatening Experiences Questionnaire (LTE-Q)
(Brugha et al. 1985). Childbirth was also included, giv-
ing a total of 12 items (Farmer et al. 2004) (online
Supplementary material). Cases in the DeCC and
DeNT studies were asked to report on whether or
not they experienced each SLE in the 6 months prior
to their worst episode of depression, while GENDEP
cases were asked to report on the 6 months preceding
the clinical trial (Keers et al. 2011; Fisher et al. 2012).
Controls reported on the 6 months prior to their inter-
view. The number of reported SLEs was summed for
each individual and analysed as a quantitative variable
with range 0–12. Following the LTE-Q categories, SLEs
were split into those considered dependent on an indi-
vidual’s behaviour and those which seem independent
(Brugha et al. 1985). Dependent SLEs included un-
employment, separation, ﬁnancial or legal difﬁculties
and the birth of a baby. Independent events included
personal illness, illness of a family member, death of
a family member and being robbed. This gave a total
of seven dependent and ﬁve independent SLEs (online
Supplementary material). Mood at the time of inter-
view was assessed using the self-report Beck
Depression Inventory in the DeCC and GENDEP
cases (Beck et al. 1996).
A subset of the sample (n = 240 cases, n = 272 con-
trols) completed the self-report Childhood Trauma
Questionnaire, which measures frequency and severity
of sexual, physical and emotional abuse, physical and
emotional neglect during childhood, using 25
Likert-type items (Bernstein et al. 2003). CT was
ﬁrstly analysed as a quantitative score with range 25–
125. To explore results, CT was divided into categories
of none, mild and moderate/severe, according to a
deﬁnition described previously in this sample (Fisher
et al. 2013). The GenRED and DGN replication studies
assessed CT with the self-report Childhood Events
Questionnaire (E. Nelson and D. Levinson, unpub-
lished observations), which is based on the US
National Comorbidity Survey CT screening items
(Kessler et al. 1997) and CT questionnaires from
Washington University (Nelson et al. 2002). These
items cover severity and frequency of sexual abuse,
physical abuse and trauma (within and outside the
family), and emotional neglect.
Quality control
Standard quality-control procedures were implemen-
ted to clean genetic data, leaving 471 747 SNPs
(Lewis et al. 2010). Principal components (PCs) were
calculated using EIGENSTRAT (Price et al. 2006). The
ﬁrst two PCs reduced the genomic control parameter
(γ) to 1.02, indicating little difference between
RADIANT UK cases and controls due to population
stratiﬁcation or other systematic genomic effects
(Lewis et al. 2010). Missing information on age at
worst episode of depression (233 cases) and age at
interview (34 controls) was replaced with the mean
age at worst episode or interview in males or females
as appropriate. Number of SLEs was signiﬁcantly asso-
ciated with age (p = 3.64 × 10−8) and sex (p = 0.001),
with younger individuals and females reporting more
SLEs. Since depressed cases were younger than con-
trols and contained a greater proportion of females,
the number of SLEs was adjusted in cases to remove
bias due to age and sex. Using controls as a proxy
for the general population, a linear regression of
SLEs on age and sex was used to estimate their associ-
ation. These regression coefﬁcients were then used to
adjust the number of SLEs in depressed cases.
Dependent and independent SLEs were adjusted sep-
arately in the same manner. CT score was not asso-
ciated with age or sex, so no adjustment was
performed.
Statistical analysis
Polygenic scores were constructed using summary
results available online from the Psychiatric
Genomics Consortium (https://pgc.unc.edu/) MDD
GWAS (Ripke et al. 2013). The RADIANT UK sample
was removed to provide an independent validation
dataset and a meta-analysis of the remaining eight
studies was conducted (7615 cases and 7931 controls).
These discovery GWAS results were pruned for link-
age disequilibrium (LD) using the p value informed
clumping method in PLINK v1.07 (http://pngu.mgh.
harvard.edu/purcell/plink/), based on the LD structure
from the RADIANT UK dataset (Purcell et al. 2007).
Clumping preferentially retains SNPs with the stron-
gest evidence of association and removes SNPs in
high LD (r2 > 0.25 within a 300 kb window, ﬁltering
for signiﬁcance, PLINK-command: --clump-p1 0.5
--clump-p2 0.1 --clump-r2 0.25 --clump-kb 300).
Subsets of SNPs were selected from the results at
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nine increasingly liberal p value thresholds (pT <
0.0001, pT < 0.001, pT < 0.01, pT < 0.05, pT < 0.1, pT < 0.2,
pT < 0.3, pT < 0.4, pT < 0.5). These sets of alleles,
weighted by their log odds ratios (ORs) from the dis-
covery study, were summarized into PRS for each indi-
vidual in the validation sample using PLINK (Purcell
et al. 2009). pT < 0.5 contained 87 737 SNPs.
PRS for MDD were tested for ability to predict case/
control status in RADIANT UK using logistic re-
gression in R (http://www.r-project.org) to calculate
the Nagelkerke’s pseudo-R2 measure of variance
explained, excluding the variance accounted for by
two PCs (Nagelkerke, 1991). SLEs and CT score were
also tested for association with case/control status.
Interactions between PRS and SLEs or CT were inves-
tigated using two models. A multiplicative model tests
interaction as departure from multiplicativity, meaning
that the combined effect of PRS and environment dif-
fers from the product of their individual effects. This
was tested using a logistic regression, co-varying for
the main effects of PRS, environment and two PCs.
Models were also adjusted for PC × environment and
PC × PRS interactions (Keller, 2014). The interaction
term was tested for its ability to differentiate between
case and control status in the validation sample by cal-
culating Nagelkerke’s pseudo-R2. An additive inter-
action model tests whether the combined effect of
PRS and environment differs from the sum of their in-
dividual effects. It has been suggested that this better
captures the biological mechanism of GxEs (Rothman
et al. 2008). Interaction as departure from additivity
was tested using linear regression of MDD case/control
status on the interaction term, with covariates as
described previously. The multiple-R2 measure of vari-
ance explained by the interaction was calculated. To in-
vestigate gene–environment correlations, whereby
genotypes may inﬂuence exposure to different envir-
onments, PRS for MDD were tested for association
with SLEs or CT score using a linear regression,
co-varying for two PCs. Empirical p values were calcu-
lated using permutation procedures for all analyses.
Ten independent tests were conducted, giving a
Bonferroni corrected signiﬁcance threshold of 0.005.
In the replication phase, gene–environment correla-
tions between PRS and CT score in depressed subjects
were tested in MDD cases from the independent
GenRED and DGN samples.
Power calculations for our study were performed in
QUANTO version 1.2.4 (Gauderman & Morrison,
2009), using ORs reported in the literature for the
effects of PRS (OR = 1.22), 2+ SLEs (OR = 1.82) and CT
(OR = 2.27) on MDD (Nanni et al. 2012; Motrico et al.
2013; Peyrot et al. 2014). The study had >80% power
to detect an interaction between PRS and SLEs with
an OR of 1.28 (at α = 0.05). In the subset with CT
data, there was >80% power to detect an interaction be-
tween PRS and CT with an OR of 1.76 (at α = 0.05).
Ethical standards
All procedures contributing to this work comply with
the ethical standards of the relevant national and institu-
tional committees on human experimentation and with
the Helsinki Declaration of 1975, as revised in 2008.
Results
Sample characteristics
Sample characteristics are shown in Table 1. Cases con-
tained a signiﬁcantly greater proportion of females
than controls and their mean age at worst episode of
depression was signiﬁcantly younger than mean age
at interview in controls. Cases had experienced signiﬁ-
cantly more SLEs and had higher CT scores than con-
trols (Table 1). In the subset of the sample with CT data
(240 cases and 272 controls), similar differences in sex
and age at interview were found between cases and
controls (p = 2.9 × 10−4 and p = 0.004, respectively).
Table 1. Sample characteristics
Cases
(n = 1605)
Controls
(n = 1064) pa
Sex, n (%) 6.83 × 10−10
Male 471 (29.3) 436 (41.0)
Female 1134 (70.7) 628 (59.0)
Age, yearsb 36.7 (12.3) 41.5 (13.2) 4.16 × 10−19
Age of onset, years 23.1 (11.4)
Number of
episodes
2.48 (0.68)
Number of SLEsb 1.57 (1.48) 0.68 (0.87) 1.67 × 10−67
Number of
dependent SLEsb
0.88 (1.05) 0.23 (0.51) 3.05 × 10−79
Number of
independent
SLEsb
0.69 (0.89) 0.44 (0.66) 1.29 × 10−11
Childhood trauma
scorec
46.31 (16.25) 32.75 (8.75) 7.13 × 10−26
Data are given as mean (standard deviation) unless other-
wise indicated.
SLEs, Stressful life events.
a p Values were calculated using a non-parametric Mann–
Whitney U test, with the exception of sex where a χ2 test
was used.
b For cases at worst episode of depression and for controls
at interview.
c Data were available on a subset of 240 cases and 272
controls. Statistics were calculated from individuals without
missing data.
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Interaction with SLEs
Polygenic scores derived from a meta-analysis of MDD
using data from the Psychiatric Genomics Consortium
showed signiﬁcant predictive ability for depression in
the RADIANT UK sample. As more SNPs were
added to the PRS at increasingly liberal p value thresh-
olds, the amount of variance explained increased. At
pT < 0.5, the polygenic score explained 1.1% of variance
in case/control status [p = 1.9 × 10−6, OR = 1.22, 95%
conﬁdence interval (CI) 1.12–1.32] (Fig. 1). After
adjustment for age and sex, total SLEs were still sign-
iﬁcantly associated with MDD status (p = 2.19 × 10−4),
explaining 0.7% of variance between cases and con-
trols. A greater number of dependent SLEs was asso-
ciated with case status and could predict 6.6% of
variance in phenotype (p = 1.35 × 10−25). Independent
SLEs showed signiﬁcant but weaker predictive ability
(p = 1.36 × 10−9, Nagelkerke’s pseudo-R2 = 0.019) and in
contrast to dependent SLEs, more independent events
were found in controls v. cases, after correction for
age and sex. Under a multiplicative model, there was
no interaction between the PRS and total number of
SLEs (Fig. 1). The largest R2 was 0.001 at pT < 0.001
(p = 0.12, OR = 1.05, 95% CI 0.98–1.12). Interactions be-
tween PRS and dependent or independent SLEs were
also non-signiﬁcant (Fig. 1). No interactions were
found under additive models (online Supplementary
material).
Interaction with CT
In the subset of the sample with CT data, the PRS did
not show signiﬁcant predictive ability for MDD (p =
0.078, Nagelkerke’s pseudo-R2 = 0.007, pT < 0.4), though
effects were in the expected direction (OR = 1.18, 95%
Fig. 1. Polygenic risk scores (PRS) for major depressive disorder and multiplicative interactions with stressful life events
(SLEs) used to predict depression in the RADIANT UK sample. The y-axis indicates Nagelkerke’s pseudo-R2, a measure of
the variance explained. On the x-axis the nine p value thresholds used to select single nucleotide polymorphisms in the
discovery phase are plotted left to right. depSLEs, Dependent SLEs; indepSLEs, independent SLEs; pT, p value threshold. * p <
0.005. For a colour ﬁgure, see the online version.
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CI 0.98–1.42) (Fig. 2). A higher CT score was signiﬁ-
cantly associated with depression status, explaining
30.2% of variance (p = 5.12 × 10−20). Multiplicative
interactions were found between polygenic scores for
MDD and CT (Fig. 2). The interaction at pT < 0.05
explained 1.9% of variance in the phenotype and was
signiﬁcant after multiple testing correction (p = 0.002).
There was an inverse association between the inter-
action and MDD status (OR = 0.96, 95% CI 0.94–0.98).
To visualize these results, interactions were plotted be-
tween categories of CT (none, mild, moderate/severe)
and PRS standardized to mean 0 and S.D. 1. Plotting
log odds of depression by polygenic score for each
CT category at the p value threshold with most signiﬁ-
cant interaction (pT < 0.05; p = 0.002) allows visualiza-
tion of the results (Fig. 3). For individuals who had
not experienced CT, a higher PRS for MDD was asso-
ciated with a higher risk of the disorder (Fig. 3; black
line). Individuals in the mild CT category were at an
increased risk of depression but this appeared to act in-
dependently of their genetic liability (mid-grey line).
Those who had experienced moderate/severe CT
were mostly depressed cases but interestingly the indi-
viduals at highest risk in this category had a lower PRS
than average (Fig. 3; light grey line). There were no
interactions between PRS and CT under additive mod-
els (online Supplementary material).
Gene–environment correlations
Gene–environment correlations were explored be-
tween PRS for MDD and number of SLEs. Signiﬁcant
correlations were found within the MDD cases, speciﬁ-
cally with dependent (pT < 0.001; p = 0.002) and not in-
dependent SLEs (online Supplementary material). No
signiﬁcant corrections were found between polygenic
score and CT score in the RADIANT UK sample (on-
line Supplementary material). As the interaction
Fig. 2. Polygenic risk scores (PRS) for major depressive disorder and multiplicative interaction with childhood trauma (CT)
used to predict depression in the RADIANT UK sample. The y-axis indicates Nagelkerke’s pseudo-R2, a measure of the
variance explained. On the x-axis the nine p value thresholds used to select single nucleotide polymorphisms in the discovery
phase are plotted left to right. pT, p value threshold. * p < 0.005. For a colour ﬁgure, see the online version.
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between PRS and CT showed an inverse association
with MDD status, the relationship between PRS and
CT score was tested in the independent GenRED and
DGN depression cases. No signiﬁcant correlations be-
tween PRS and CT score were found.
Mood at interview
To investigate whether low mood at the time of inter-
view may result in a recall bias for negative events,
cases severely depressed at interview were removed in
a sensitivity analysis. Gene–environment correlations
between PRS and dependent SLEs in cases were no
longer signiﬁcant, excluding those who were severely
depressed at interview (online Supplementary mater-
ial). Interactions between PRS and CT score remained
signiﬁcant after severely depressed cases were excluded
(online Supplementary material).
Discussion
Polygenic scores derived from the Psychiatric Genomics
Consortium MDD mega-analysis predicted depression
in the RADIANT UK sample, explaining 1.1% of vari-
ance in case/control status. This modest ﬁgure is in
line with previous estimates from this mega-analysis
and conﬁrms the presence of associated variants that
Fig. 3. Multiplicative interaction between standardized polygenic risk score for major depressive disorder (MDD) based on pT
< 0.05 and categories of childhood trauma. Shaded circles are cases and open circles are controls. pT, p value threshold. For a
colour ﬁgure, see the online version.
Polygenic interactions with environmental adversity and major depressive disorder 765
the original GWAS was underpowered to detect (Ripke
et al. 2013; Peyrot et al. 2014). SLEs were also signiﬁcant
predictors of case/control status. We hypothesized that
given the polygenicity of MDD, testing interactions be-
tween polygenic scores and environmental adversity
could be a more powerful approach than using single
genetic variants in a candidate gene. No interactions
were found between PRS for MDD and total, dependent
or independent SLEs, which is in agreement with previ-
ous ﬁndings by Musliner et al. (2015).
In the subset of the sample with CT data, the PRS
failed to show signiﬁcant predictive ability for depres-
sion which probably reﬂects the restricted sample size.
Consistent with previous reports, CT was a strong risk
factor for recurrent MDD in adulthood (Nanni et al.
2012). Signiﬁcant interactions were found between
PRS and CT; however, there was an inverse association
with depression status. This appeared to be driven by
individuals who had experienced moderate/severe CT,
as those at highest risk in this category tended to have
a lower PRS than other cases or controls (Fig. 3). One
possible explanation is that CT may be more important
in the development of MDD for individuals who have
a low genetic risk than for individuals who have a high
genetic risk. This would be consistent with the liability
threshold model for MDD, where a combined effect of
many genetic risk variants together with an environ-
mental contribution causes an individual to cross the
liability threshold and become affected. Alternatively,
the experience of CT may be such a strong risk factor
for depression that genetics has a negligible effect.
In contrast to our results, the NESDA study found a
signiﬁcant PRS x CT interaction, whereby higher PRS
and severe CT increased the risk for MDD (Peyrot et al.
2014). The conﬂicting results of these studies may be
due to differences in design – for example, NESDA is a
population-based study, includes single-episode, recur-
rent and chronic depression, used a different instrument
for assessing CT and had a larger sample size (1645
MDD cases, 340 controls). It has been reported that inter-
action between 5-HTTLPR and CT speciﬁcally increases
risk for chronic depression in adulthood (Brown et al.
2013). This suggests that GxEs may be more speciﬁc
than anticipated and subtle differences between our
study and NESDA could have contributed to the dis-
crepant results. Similarly, our SLE assessment was for
the 6 months prior to the worst episode of depression
in recurrent depression cases. Testing SLEs preceding
the initial onset of depression or in single-episode de-
pression may identify different components of the
gene–environment aetiology of MDD.
Evidence of gene–environment correlation was
found, as polygenic scores for MDD increased expos-
ure to (or reporting of) dependent SLEs in MDD
cases (online Supplementary material). This suggests
that depressed individuals may select themselves into
environmental adversity by creating stressful life
events due to their own behaviour, which is known
as active gene–environment correlation. SLEs or the
reporting of SLEs is heritable (Power et al. 2013) and
twin studies have shown pleiotropy between the gen-
etic contribution to SLEs and genetic liability to de-
pression (Kendler & Karkowski-Shuman, 1997;
Silberg et al. 1999).
There are several strengths of this study. SLEs were
adjusted for age and sex prior to the analyses. The
amount of variance explained by the SLEs decreased
dramatically after adjustment (online Supplementary
material), which demonstrates the importance of
accounting for age and sex. It has been suggested
that low mood at the time of interview may cause re-
call bias for negative events; however, we found no
evidence that this inﬂuenced our results, consistent
with two previous analyses in the RADIANT UK sam-
ple (Fisher et al. 2012, 2013).
A number of limitations also warrant noting. The
discovery GWAS by the Psychiatric Genomics
Consortium was underpowered to detect the likely ef-
fect sizes in MDD, which reduces the ability to separate
modest signals from noise and achieve accuracy in es-
timation of the PRS (Dudbridge, 2013; Ripke et al.
2013). The PRS used in these analyses consists of
SNPs selected from a study of their main effect on
MDD, which may not be the same genetic variants
that are involved in GxEs. This could explain the non-
standard shape of the PRS histograms for the interac-
tions, in contrast to the usual pattern where variance
explained increases across the p value thresholds
(Figs 1 and 2). Our study design relied on retrospective
self-reports of depression and environment, which
may be less accurate if the events occurred a long
time ago. However, the worst episode of depression
is arguably the most memorable, and retrospective
self-reports of depressive episodes agree well with hos-
pital records (McGufﬁn et al. 1986; Kendler et al. 1993).
The detection of GxEs has implications for future re-
search strategies. Analysis of cohorts with heteroge-
neous environmental exposures may partially explain
the lack of success in detecting genetic associations
with MDD. Our results suggest that more power
could be leveraged from GWAS by focusing only on
individuals not exposed to CT as this might identify
‘more genetic’ cases of MDD. However, results of the
NESDA study suggest that focusing on exposed indivi-
duals could render genetic effects larger, more homo-
geneous and easier to detect (Flint & Kendler, 2014;
Peyrot et al. 2014). Polygenic interactions in MDD re-
quire further investigation in larger, similarly well-
characterized samples and could provide important
insights into the complex aetiology of depression.
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